LI
VERA icon

LRI Investments’s Vera Therapeutics VERA Stock Holding History

LRI Investments’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$772 Hold
18
– – ﹤0.01% 1438
2026
Q1 		$724 Hold
18
– – ﹤0.01% 1347
2025
Q4 		$912 Buy
+18
New +$639 ﹤0.01% 1270

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LRI Investments's VERA Position: Q2 2026 in Review

LRI Investments held its Vera Therapeutics (VERA) position steady in Q2 2026 at 18 shares worth $772. The position accounts for ﹤0.01% of the portfolio, ranked #1438.

LRI Investments first reported a position in VERA in Q4 2025 and has held it in 3 quarters since. The position peaked at $912 in Q4 2025. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • LRI Investments held 18 shares of Vera Therapeutics worth $772 as of Q2 2026.
  • LRI Investments left its Vera Therapeutics share count unchanged in Q2 2026.
  • Vera Therapeutics made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #1438 holding.
  • LRI Investments first reported a position in Vera Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • LRI Investments's Vera Therapeutics position peaked at $912 in Q4 2025.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.